Literature DB >> 30201327

Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP).

Francesca Granata1, Manuel Mendez2, Valentina Brancaleoni1, Francisco J Castelbon2, Giovanna Graziadei1, Paolo Ventura3, Elena Di Pierro4.   

Abstract

Genetic variants in promoters and alternative-splicing lesions require to be experimentally tested in order to validate them as causatives of a disease. The digital PCR (dPCR) approach, which is an alternative to the classical qPCR, is an innovative and a more sensitive method for the detection and quantification of nucleic acids. In the present study, we identified four HMBS gene mutations affecting the ubiquitous isoform of porphobilinogen deaminase (PBGD) and established a dPCR protocol which would be able to detect the different transcripts of this gene. With the application of this method, we were able to characterize the functional roles of these four genetic variants, demonstrating that all these mutations were causatives of the non-erythroid variant of the acute intermittent porphyria (AIP) disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Digital PCR; Gene expression; HMBS; Porphyria; Promoter variants; Splicing isoform

Mesh:

Substances:

Year:  2018        PMID: 30201327     DOI: 10.1016/j.ymgme.2018.09.002

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  2 in total

1.  Acute intermittent porphyria: prevalence of pathogenic HMBS variants in China, and epidemiological survey in Hebei Province, China.

Authors:  Liyan Ma; Yu Tian; Xuan Qi; Pei Li; Jie Li; Qing Teng; Yuelin Ma; Songyun Zhang
Journal:  Ann Transl Med       Date:  2022-05

2.  Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients.

Authors:  Francesca Granata; Valentina Brancaleoni; Jasmin Barman-Aksözen; Margherita Scopetti; Giacomo De Luca; Silvia Fustinoni; Irene Motta; Elena Di Pierro; Giovanna Graziadei
Journal:  Front Physiol       Date:  2022-07-18       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.